Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Innate Pharma (IPHA) Debt Ratio (2017 - 2025)

Innate Pharma posted quarterly Debt Ratio of 0.36 for Q4 2025, up 28.96% year-on-year from 0.28 in Q4 2024, and up 23.75% on a QoQ basis from 0.29 in Q2 2025.

Innate Pharma (IPHA) has 9 years of Debt Ratio data on file, last reported at 0.36 in Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 28.96% year-over-year to 0.36; the trailing twelve-month figure through Dec 2025 stood at 0.36 (up 28.96% YoY), and the FY2025 full-year result was 0.36, up 28.96% from the prior year.
  • Debt Ratio for Q4 2025 stood at 0.36, up from 0.29 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.36 in Q4 2025 and bottomed at 0.06 in Q2 2021.
  • The 5-year median for Debt Ratio is 0.22 (2023), against an average of 0.22.
  • Peak annual rise in Debt Ratio reached 166.44% in 2021, while the deepest fall reached 9.72% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.17 in 2021, then rose by 22.87% to 0.2 in 2022, then gained by 12.03% to 0.23 in 2023, then advanced by 22.56% to 0.28 in 2024, then rose by 28.96% to 0.36 in 2025.
  • The last three Debt Ratio figures came in at 0.36 (Q4 2025), 0.29 (Q2 2025), and 0.28 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 0.18
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 1.41
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.05
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -
10 Innate Pharma 199.64 Mn 199.64 Mn - 0.36

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.36
Jun 30, 2025 0.29
Dec 31, 2024 0.28
Jun 30, 2024 0.23
Dec 31, 2023 0.23
Jun 30, 2023 0.20
Dec 31, 2022 0.20
Jun 30, 2022 0.15
Dec 31, 2021 0.17
Jun 30, 2021 0.06
Dec 31, 2020 0.06
Jun 30, 2020 0.06
Dec 31, 2019 0.05
Dec 31, 2018 0.01
Dec 31, 2017 0.02